Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Whiplash-associated Disorders - Needling Treatments Pilot Study

NCT01824810

Whiplash Injury

UNKNOWN NA

Treatment for Whiplash Injury

NCT04959721

Cervical Facet Joint Pain

UNKNOWN NA

Facet Versus Trigger Point Injections for Chronic Neck Pain

NCT01808586

Neck Pain

COMPLETED PHASE2

Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.

NCT01250184

Myofascial Pain Syndrome Pain Myofascial Trigger Point Pain +1 more

COMPLETED PHASE4

Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient

NCT04040218

Dry Needling Harm

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Whiplash Injuries Neck Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lidocaine

The treatment group will receive a 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point. Three to five points injection.

Group Type EXPERIMENTAL

Lidocaine

Intervention Type PROCEDURE

Lidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point).

Saline

The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.

Group Type ACTIVE_COMPARATOR

Saline

Intervention Type OTHER

The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lidocaine

Lidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point).

Intervention Type PROCEDURE

Saline

The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* fulfill the Grade II Quebec Task Force classification of WAD,
* with identifiable myofascial trigger points ( which occur with or without a taut band),
* reproduction of recognizable pain with sustained pressure ( up to 10 seconds) on trigger points
* aged 18 to 70
* a good understanding of informed consent and willing to attend this trial.

Exclusion Criteria

* have serious injury such as fracture and internal bleeding
* suspicion of upper cervical instability or neurological deficits
* clinical evidence of radiculopathy
* a history of active cancer, central nerve disorder, blood clotting disorders, needle phobia
* anticoagulant medication user
* previous experience with any type of needling for myofascial pain

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No